“…Enantiomerically enriched Michael adduct 7 , which was obtained with catalyst ( S , S )- C5 , was also used to finish the synthesis of 4-methylpregabalin ( 1 ) in an analogy to literature procedures ( Scheme 4 ) [ 47 ]. Adduct 7 was transformed to lactone 13 via nitro group reduction with NaBH 4 /NiCl 2 followed by spontaneous lactamization.…”
Chiral derivatives of γ-aminobutyric acid are widely used as medicines and can be obtained by organocatalytic Michael additions. We show here the stereoselective synthesis of 4-methylpregabalin stereoisomers using a Michael addition of dimethyl malonate to a racemic nitroalkene. The key step of the synthesis operates as a kinetic resolution with a chiral squaramide catalyst. Furthermore, specific organocatalysts can provide respective stereoisomers of the key Michael adduct in up to 99:1 er.
“…Enantiomerically enriched Michael adduct 7 , which was obtained with catalyst ( S , S )- C5 , was also used to finish the synthesis of 4-methylpregabalin ( 1 ) in an analogy to literature procedures ( Scheme 4 ) [ 47 ]. Adduct 7 was transformed to lactone 13 via nitro group reduction with NaBH 4 /NiCl 2 followed by spontaneous lactamization.…”
Chiral derivatives of γ-aminobutyric acid are widely used as medicines and can be obtained by organocatalytic Michael additions. We show here the stereoselective synthesis of 4-methylpregabalin stereoisomers using a Michael addition of dimethyl malonate to a racemic nitroalkene. The key step of the synthesis operates as a kinetic resolution with a chiral squaramide catalyst. Furthermore, specific organocatalysts can provide respective stereoisomers of the key Michael adduct in up to 99:1 er.
“…13 C {1H} NMR (101 MHz, CDCl 3 ): δ 168.0, 167.4, 150.0, 147.7, 128.2, 120.0, 114.7, 112.0, 80.5, 77.8, 55.9, 54.9, 53.0, 52.9, 42.7, 32.8, 24.1. NMR spectra are in agreement with the literature data …”
Section: Methodsmentioning
confidence: 99%
“…mp 95−96 °C. 1 57 Dimethyl (R)-2-(4-Methyl-1-nitropentan-2-yl)malonate (1m). A 10 mL screw-cap Schlenk tube with a stirring bar was prepared according to a standard Schlenk procedure, and 15 mg (5 mol %) of the precatalyst NiBr 2 -Cat-2 was placed inside as an aliquot in chloroform followed by the addition of 9.48 mg (4 mol %) of TBAT as an aliquot in chloroform.…”
Nowadays, design of the new chiral ligands for organometallic catalysts is often based on the step-by-step increase in their complexity to improve efficiency. Herein we describe that simple in situ addition of the fluoride source to the asymmetric organometallic catalyst can improve not only activity but also enantioselectivity. Bromide−nickel diimine complexes were found to catalyze asymmetric Michael addition in low yields and ee, but activation with fluoride leads to a significant improvement in catalyst performance. The developed approach was applied to prepare several enantioenriched GABA analogues.
“…Finally, the nitro groups can be further reduced to obtain the GABA or tryptamine scaffold, respectively. The replacement of soluble catalysts– by heterogeneous counterparts simplifies the removal of the catalyst from the reaction mixture and may allow its reuse . Herein, a new family of post synthetically modified metal–organic frameworks is employed to selectively direct the different C−C bond‐forming reactions towards desired products 2 and 3 starting from benzaldehyde and nitromethane as starting materials.…”
Copper‐ion‐exchanged nickel pyrazolate frameworks behave as selective heterogeneous catalysts for the one‐pot, two‐step (Henry reaction/Michael type addition) synthesis of neuroactive pharmaceutical intermediates starting from nitromethane and benzaldehyde. Tuning the basicity of multifunctional metal–organic framework catalysts through ion exchange with copper(II) cations allows the tandem C−C bond‐forming process to be selectively directed towards the desired pharmaceutical intermediate.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.